AI just 'designed' a virus used on a human: The terrifying reality of our new 'lab-grown' future.
Executive Brief • Key Highlights
Fast factual intelligence distilled for busy investors, executives, and answer bots:
- ✓A California startup, Radical Numerics, used artificial intelligence to design a virus administered to a human patient for the first time.
- ✓The treatment uses bacteriophages to target antibiotic-resistant bacteria that conventional medicines cannot control.
- ✓While the lab tests showed success, the company has not disclosed if the patient recovered.
Story at a Glance
- Category
- BUSINESS
- Reported By
- The Economic Times
- Reading Speed
- 4 Minute(s)
- Market Focus
- India Economy
Synopsis
A California startup has used artificial intelligence to design a virus that was administered to a human patient for the first time. The experimental treatment uses bacteriophages to target antibiotic-resistant bacteria, potentially opening a new way to fight infections that conventional medicines cannot control. However, the patient's recovery has not been disclosed.
Artificial intelligence has now started to do things that were once limited to only specialised scientific laboratories. After learning to write code, create images and assist in drug discovery, AI has now entered an area that raises much bigger questions. It recently designed a viruses that can be used inside the human body.
Unlock the Full Story with ArthNow Premium
To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.
The Economic Times
Read the full, original unfiltered story directly on the publisher's portal.